Celcuity Inc Schedules Release of Third Quarter 2023 Financial Results and WebcastConference Call

MINNEAPOLIS, Nov. 06, 2023 (GLOBE NEWSWIRE) — Celcuity Inc. (Nasdaq: CELC), a clinical-stage biotechnology company pursuing development of targeted therapies for oncology, today announced that it will release its financial results for the third quarter 2023 before the market opens on Monday, November 13, 2023. Management will host a webcast/teleconference…Read More

Leave a Reply

Your email address will not be published. Required fields are marked *